Alkem Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

5569.25

+86.55 (+1.58%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

5569.25

+86.55 (+1.58%)
15:53 Dec 30

Quality

84/100
High Financial Strength

Valuation

37/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Net Sales	8344.36	8865.01	10634.19	11599.26	12667.58
Operating Expenses +	6870.97	6922.62	8581.27	9989.81	10422.09
Raw Material	3574.89	3832.3	4715.77	4444.47	4923.46
Increase Decrease in Cost	-229.95	-333.84	-535.48	462.37	14.12
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1505.49	1621.03	1962.71	2131.35	2201.01
Miscellaneous Expenses	4906.66	4678.65	5417.69	5726.72	6541.24
Operating Profit	1473.39	1942.39	2052.92	1609.45	2245.49
Other Income	104.22	233.21	162.65	216.08	310.84
Depreciation	252.76	274.58	303.96	310.42	299.3
Interest	65.06	58.92	52.37	107.36	112.41
Profit before tax and exceptio..	1259.79	1842.1	1859.24	1407.75	2144.62
Exceptional Items	0	0	-14.96	-102.98	-121.49
PBT	1259.79	1842.1	1844.28	1304.77	2023.13
Provision for Taxation	110.48	224.33	163.96	297.96	211.67
Net Profit	1149.31	1617.77	1680.32	1006.81	1811.46
NET Profit after MI	1127.07	1585.02	1645.62	984.17	1795.77
EPS	94.26	132.57	137.63	82.31	150.19
Operating Profit Margin (%)	17.66	21.91	19.3	13.88	17.73
Net Profit Margin (%)	13.51	17.88	15.47	8.48	14.18

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	55.70	56.40	56.70	56.70	56.70
FII	9.00	8.70	9.10	8.50	6.00
MF	14.90	14.70	11.90	12.10	13.00
Public	16.10	16.40	18.50	18.90	19.60
Others	0.00	0.00	0.10	0.00	0.00
Others	4.30	3.80	3.70	3.80	4.70